As of Friday close, Exelixis Inc.’s (NASDAQ:EXEL) stock was down -$0.1, moving down -0.46 percent to $21.48. The average number of shares traded per day over the past five days has been 2,183,680 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.33 fall in that time frame. In the last twenty days, the average volume was 2,231,755, while in the previous 50 days, it was 2,321,306.
Since last month, EXEL stock retreated -1.24%. Shares of the company fell to $21.30 on 09/20/23, the lowest level in the past month. A 52-week high of $22.80 was reached on 09/01/23 after having rallying from a 52-week low of $14.87. Since the beginning of this year, EXEL’s stock price has risen by 33.92% or $5.44, and marked a new high 28 times. However, the stock has declined by -5.77% since its 52-week high.
EXEL stock investors should be aware that Exelixis Inc. (EXEL) stock had its last reported insider trading activity 24 days ago on Aug 30. Aftab Dana, the CSO/EVP Disc & Trans Research of the company, disposed of 4,600 shares for $22.47 on Aug 30. It resulted in a $103,362 divestment by the insider. Senner Christopher J. sold 60,000 shares at an average price of $20.68 on Aug 04. The insider now owns 571,631 shares following the transaction. On Aug 03, EVP and CFO Senner Christopher J. sold 60,000 shares at $20.51 apiece. The transaction was valued at $1,230,600.
Valuation Metrics
Right now, Exelixis Inc. (EXEL) has a P/E ratio of about 42.70. The stock’s beta is 0.67. Besides these, the trailing price-to-sales (P/S) ratio of 4.07, the price-to-book (PB) ratio of 2.75, and the price-to-cash flow ratio of 19.32 may also be considered.
Financial Health
In the three months ended June 29, Exelixis Inc.’s quick ratio stood at 4.60, while its current ratio was 4.70, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 96.30% percent. In the year ended June 29, EBITDA margin amounted to 14.94%, whereas operating margins totaled 8.20%. Based on annual data, EXEL earned $1.55 billion in gross profit and brought in $1.61 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 6.00%. Return on equity (ROE) for the past 12 months was 6.50%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. EXEL’s revenue rose 10.73% to $408.79 million during the quarter, while net income inched up to $469.85 million. While analysts expected Exelixis Inc. to report $0.16 quarterly earnings, the actual figure was $0.25 per share, beating the consensus estimate by 56.20%. During the quarter, the company generated $83.89 million in EBITDA. The liabilities of Exelixis Inc. were 614.53 million at the end of its most recent quarter ended June 29, and its total debt was $194.69 million. The value of shareholders’ equity is $318.38 million.
Technical Picture
This quick technical analysis looks at Exelixis Inc.’s (EXEL) price momentum. With a historical volatility rate of 16.12%, the RSI 9-day stood at 40.11% on 22 September.
With respect to its five-day moving average, the current Exelixis Inc. price is down by -1.51% percent or -$0.33. At present, EXEL shares trade -1.24% below its 20-day simple moving average and +14.07% percent above its 100-day simple moving average. However, the stock is currently trading approximately +11.01% above its SMA50 and +24.74% above its SMA200.
Stochastic coefficient K was 15.09% and Stochastic coefficient D was 12.31%, while ATR was 0.35. Given the Stochastic reading of 12.50% for the 14-day period, the RSI (14) reading has been calculated as 46.80%. As of today, the MACD Oscillator reading stands at -0.22, while the 14-day reading stands at -0.35.
Analyst Ratings
Oppenheimer reiterated its an Outperform rating on Exelixis Inc. (NASDAQ: EXEL) in a note to investors. The analysts firm has however raised their price target to $29, representing a possible 14.08% increase in the stock price. Exelixis Inc. (EXEL) has been rated Overweight by analysts. According to 1 brokerage firm, EXEL is a sell, and 4 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Exelixis Inc. stock as buy, with 12 recommending it as overweight.
